Travere Therapeutics, Inc. Quarterly Interest Expense in USD from Q3 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Travere Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2010 to Q1 2024.
  • Travere Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $2.8M, a 3.45% decline year-over-year.
  • Travere Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $11.2M, a 1.75% decline year-over-year.
  • Travere Therapeutics, Inc. annual Interest Expense for 2023 was $11.3M, a 2.73% increase from 2022.
  • Travere Therapeutics, Inc. annual Interest Expense for 2022 was $11M, a 44.2% decline from 2021.
  • Travere Therapeutics, Inc. annual Interest Expense for 2021 was $19.7M, a 3.14% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $11.2M $2.8M -$100K -3.45% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $11.3M $2.7M $0 0% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $11.3M $2.8M $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $11.3M $2.9M -$100K -3.33% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $11.4M $2.9M +$400K +16% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $11M $2.7M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $2.8M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $3M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $2.5M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2014 $7.4M $6.98M +$6.94M +16689% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $463K $2.6M +$2.6M Jul 1, 2014 Sep 30, 2014 10-K 2015-03-11
Q2 2014 -$2.14M -$2.18M -$2.18M Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-14
Q1 2014 $41.6K $0 +$41.6K Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-15
Q4 2013 $0 $41.6K +$41.1K Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 -$41.1K $0 -$26.8K -100% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-11
Q2 2013 -$14.3K -$5* +$26.5K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$40.8K -$41.6K -$24.2K -140% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$16.5K $500* $0 Sep 1, 2012 Nov 30, 2012 10-Q 2013-03-06
Q3 2012 -$16.5K $26.8K +$26.3K Jul 1, 2012 Sep 30, 2012 10-Q/A 2015-07-09
Q2 2012 -$42.8K -$26.5K -$27K Apr 1, 2012 Jun 30, 2012 10-Q 2013-09-16
Q1 2012 -$15.8K -$17.3K Jan 1, 2012 Mar 31, 2012 10-Q/A 2013-09-16
Q4 2011 $500* Sep 1, 2011 Nov 30, 2011 10-Q 2013-03-06
Q3 2011 $500* -$3.13K Jun 1, 2011 Aug 31, 2011 10-Q 2012-10-10
Q2 2011 $500* Mar 1, 2011 May 31, 2011 10-Q 2012-08-08
Q3 2010 $3.63K* Jun 1, 2010 Aug 31, 2010 10-Q/A 2012-06-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.